International Patent: A GENE EXPRESSION-BASED MOLECULAR BIOMARKER TO IDENTIFY LUNG TRANSPLANT RECIPIENTS WITH CHRONIC LUNG ALLOGRAFT DYSFUNCTION

GENEVA, Aug. 31 -- THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS filed a patent application (US2026/016490) for “A GENE EXPRESSION-BASED MOLECULAR BIOMARKER TO IDENTIFY LUNG TRANSPLANT RECIPIENTS WITH CHRONIC LUNG ALLOGRAFT DYSFUNCTION”. With publication no. WO/2026/178561, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G16B 25/10

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....